New approaches are underway for treating nonalcoholic steatohepatitis.

Vaccine development for COVID-19 may have been rapid, but no one has scrimped on safety.

Small-molecule Sb9 inhibitor targets both cancer and associated cells to suppress tumor growth in mice.

In this eBook, thought leaders from Cambrex discuss market opportunities, drug development challenges, and more.

Biocatalysis is an increasingly attractive option in pharmaceutical synthesis.

Pharma hasn’t always covered itself in glory – but as the world scrambles for viable COVID-19 interventions, it has a rare opportunity to rebrand.

How can we get macromolecules across the intestinal epithelial barrier?

Vectura has more than 20 years’ experience in helping customers bring inhaled medicines to the market.

We Sit Down With Sandy Macrae, Chief Executive Officer, Sangamo Therapeutics, USA.

The increasing complexity of biologics raises significant manufacturing challenges – not least regarding cost control and downstream purification.